Related Experiment Video
Updated: Aug 6, 2025

07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.5K
Differential Gene Expression Among Patients With Heart Failure Experiencing Pain
Nursing Research
|March 15, 2023
Summary
Chronic pain in heart failure (HF) is linked to poor outcomes. This study identified key genes, including MMP8, PCSK9, and DEFA3, involved in immune and inflammatory pathways, offering new insights into pain mechanisms in HF patients.
Area of Science:
- Genomics
- Cardiology
- Pain Medicine
Background:
- Chronic pain is prevalent in heart failure (HF) patients, worsening outcomes and quality of life.
- The genetic basis of chronic pain in HF remains poorly understood, hindering the development of targeted interventions.
Purpose of the Study:
- To identify genes associated with chronic pain in individuals with heart failure (HF) using messenger RNA (mRNA) sequencing data.
- To explore the mechanistic underpinnings of pain in HF by analyzing gene expression patterns.
Main Methods:
- Analyzed mRNA sequencing data from 40 HF patients with and without pain.
- Utilized DESeq2 for differential gene expression analysis and Metascape for protein-protein interaction (PPI) and pathway analysis.
- Validated key gene candidates in a separate cohort of 24 HF patients using quantitative polymerase chain reaction (qPCR).
Main Results:
- Identified 334 differentially expressed genes between HF patients with and without pain, primarily linked to neutrophil degranulation pathways.
- Pinpointed seven candidate genes from a core PPI network, with MMP8, PCSK9, and DEFA3 showing consistent upregulation in painful HF.
- These seven genes are implicated in immune, inflammatory, and atherosclerotic processes.
Conclusions:
- The study identifies MMP8, PCSK9, and DEFA3 as potential key genes contributing to chronic pain mechanisms in heart failure.
- These findings provide a foundation for further research into novel therapeutic strategies for pain management in HF.
- Further investigation is warranted to validate these genes across distinct pain phenotypes in HF.
Related Concept Videos
Heart Failure II: Pathophysiology
19
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure III: Clinical Manifestations
30
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
30
Heart Failure VII: Nursing Interventions
129
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
129
Heart Failure I: Introduction
29
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
29
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
479
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479

